Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fasedienol Nasal Spray for Acute Anxiety in Social Anxiety Disorder
NCT06809179Phase 2Completed
- Sponsor
- Vistagen Therapeutics
- Start
- Jan 2025
- Primary completion
- Jun 2026
- Countries
- 1
01
Overview
A Phase 2 trial of fasedienol in Social Anxiety Disorder (SAD), sponsored by Vistagen Therapeutics. Started Jan 2025; status: completed.
02
Drugs
fasedienol
03
Conditions
Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on NCT06809179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06809179.